Similar articles

• [Was another consensus document on treating exacerbations of chronic obstructive pulmonary disease needed?].

  Llor Vilà C, Naberan Toña K. Llor Vilà C, et al. Arch Bronconeumol. 2004 Jun;40(6):290-1; author reply 291-2. Arch Bronconeumol. 2004. PMID: 15161599 Spanish. No abstract available.
• [About the second consensus document for antimicrobial use in exacerbations of COPD].

  Llor Vilà C, Naberan Toña K. Llor Vilà C, et al. Rev Esp Quimioter. 2003 Dec;16(4):453-4. Rev Esp Quimioter. 2003. PMID: 14961141 Spanish. No abstract available.
• [Use of antibiotics in the exacerbation of chronic obstructive pulmonary disease].

  Alvarez F, Bouza E, García-Rodríguez JA, Mayer MA, Mensa J, Monsó E, Nodar E, Picazo JJ, Sobradillo V, Torres A. Alvarez F, et al. Rev Esp Quimioter. 2001 Mar;14(1):87-96. Rev Esp Quimioter. 2001. PMID: 11376355 Review. Spanish. No abstract available.
• Inhibitory effects of macrolide antibiotics on exacerbations and hospitalization in chronic obstructive pulmonary disease in Japan: a retrospective multicenter analysis.

  Yamaya M, Azuma A, Tanaka H, Takizawa H, Chida K, Taguchi Y, Mikasa K, Kadota J, Kudoh S. Yamaya M, et al. J Am Geriatr Soc. 2008 Jul;56(7):1358-60. doi: 10.1111/j.1532-5415.2008.01725.x. J Am Geriatr Soc. 2008. PMID: 18774970 No abstract available.
• [Antibiotics for exacerbations of chronic obstructive pulmonary disease].

  Lange P. Lange P. Ugeskr Laeger. 2007 May 7;169(19):1780-2. Ugeskr Laeger. 2007. PMID: 17537351 Review. Danish. No abstract available.